Prime Medicine Inc (PRME)

$4.28 +0.10 (2.39%)
Market Cap 799.66M
Revenue (ttm) 2.98M
Net Income (ttm) -195.88M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -6,573.15%
Debt to Equity Ratio 0.00
Volume 2,183,510
Avg Vol 3,743,632
Day's Range N/A - N/A
Shares Out 180.51M
Stochastic %K 46%
Beta 2.71
Analysts Strong Sell
Price Target $6.46

Company Profile

Prime Medicine, Inc., a biotechnology company, engages in delivering genetic therapies to address the spectrum of diseases by deploying gene editing technology in the United States. It offers Prime Editing technology comprising a programmable DNA binding domains, such as Cas domains, are typically modified such that they do not cause a double-stranded break in the DNA, as well as a RT domain that copies the edited DNA sequence directly into the target genomic site where the edit is made; and peg...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 465 0013
Address:
60 First Street, Cambridge, United States
Elamenape2
Elamenape2 Jan. 27 at 10:10 PM
$PRME
0 · Reply
arg195
arg195 Jan. 27 at 8:33 PM
$PRME wow look at that short squeeze predicted by our great 15 min chart reader @PorkchopSquats 😂😂
0 · Reply
IgotOptionsHere
IgotOptionsHere Jan. 27 at 8:23 PM
$PRME investors sitting on a pile of trash!
1 · Reply
PorkchopSquats
PorkchopSquats Jan. 27 at 6:21 PM
$PRME Just had to open my big dumb mouth.
0 · Reply
Mcnulty_jimmy
Mcnulty_jimmy Jan. 27 at 6:15 PM
$PRME its
0 · Reply
IgotOptionsHere
IgotOptionsHere Jan. 27 at 6:08 PM
$PRME what a steaming pile of shit!
0 · Reply
THE_Monkey_Banana_Genius
THE_Monkey_Banana_Genius Jan. 27 at 4:48 PM
$PRME setup on chart looks ripe. Long
1 · Reply
Montu11
Montu11 Jan. 27 at 4:28 PM
$PRME looking good this morning, but I’m conditioned now to know that this stock can’t seem to hold any gains for more than a couple days. Hoping to be proven wrong
1 · Reply
Benpsf
Benpsf Jan. 27 at 4:11 PM
$PRME Prime Medicine - Triple Bottom📈 Prime looks to have bottomed and is moving higher in the ascending channel
0 · Reply
KirRoyalTrader
KirRoyalTrader Jan. 27 at 3:08 PM
$PRME A prime setup for Prime Medicine, trading above all major moving averages. Notably, GOOGL holds this stock in its portfolio.
0 · Reply
Latest News on PRME
Prime Medicine, Inc. (PRME) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 14, 2026, 2:16 PM EST - 13 days ago

Prime Medicine, Inc. (PRME) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Prime Medicine to Present at 44th Annual J.P. Morgan Healthcare Conference

Jan 7, 2026, 8:00 AM EST - 20 days ago

Prime Medicine to Present at 44th Annual J.P. Morgan Healthcare Conference

Prime: Maintaining 'Buy' On Solidified Catalysts For Wilson's Disease And Beyond

Dec 31, 2025, 1:29 PM EST - 27 days ago

Prime: Maintaining 'Buy' On Solidified Catalysts For Wilson's Disease And Beyond

Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease

Dec 7, 2025, 8:05 AM EST - 7 weeks ago

Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease

Prime Medicine to Present at 8th Annual Evercore Healthcare Conference

Nov 25, 2025, 8:00 AM EST - 2 months ago

Prime Medicine to Present at 8th Annual Evercore Healthcare Conference

Prime Medicine, Inc. (PRME) Discusses Liver Disease Franchise Strategy With Focus on Wilson Disease Transcript

Nov 12, 2025, 2:51 PM EST - 2 months ago

Prime Medicine, Inc. (PRME) Discusses Liver Disease Franchise Strategy With Focus on Wilson Disease Transcript

Prime Medicine to Present at Jefferies Global Healthcare Conference

Nov 11, 2025, 8:00 AM EST - 2 months ago

Prime Medicine to Present at Jefferies Global Healthcare Conference

CORRECTION - Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates

Nov 7, 2025, 10:21 AM EST - 2 months ago

CORRECTION - Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates

Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates

Nov 7, 2025, 7:00 AM EST - 2 months ago

Prime Medicine Reports Third Quarter 2025 Financial Results and Provides Business Updates

Prime Medicine Appoints Matthew Hawryluk, Ph.D., M.B.A. as Chief Business Officer

Nov 3, 2025, 8:01 AM EST - 3 months ago

Prime Medicine Appoints Matthew Hawryluk, Ph.D., M.B.A. as Chief Business Officer

Prime Medicine to Host Virtual KOL Event to Showcase Wilson's Disease Strategy

Oct 30, 2025, 4:01 PM EDT - 3 months ago

Prime Medicine to Host Virtual KOL Event to Showcase Wilson's Disease Strategy

Prime Medicine to Participate in Upcoming Investor Conferences

Oct 7, 2025, 8:00 AM EDT - 4 months ago

Prime Medicine to Participate in Upcoming Investor Conferences

Prime Medicine, Inc. (PRME) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 8, 2025, 5:38 PM EDT - 5 months ago

Prime Medicine, Inc. (PRME) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Prime Medicine, Inc. (PRME) Presents At Citi's Biopharma Back To School Conference Transcript

Sep 2, 2025, 8:07 PM EDT - 5 months ago

Prime Medicine, Inc. (PRME) Presents At Citi's Biopharma Back To School Conference Transcript

Prime Medicine Reports Second Quarter 2025 Financial Results and Provides Business Updates

Aug 7, 2025, 8:00 AM EDT - 6 months ago

Prime Medicine Reports Second Quarter 2025 Financial Results and Provides Business Updates

Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

Aug 1, 2025, 4:01 PM EDT - 6 months ago

Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

Prime Medicine Announces Pricing of Public Offering

Jul 30, 2025, 9:33 PM EDT - 6 months ago

Prime Medicine Announces Pricing of Public Offering

Prime Medicine Announces Proposed Public Offering of Common Stock

Jul 30, 2025, 4:01 PM EDT - 6 months ago

Prime Medicine Announces Proposed Public Offering of Common Stock

Cystic Fibrosis Foundation Commits Up to an Additional $24 Million for Prime Medicine to Develop Gene Editing Therapy

Jul 16, 2025, 8:10 AM EDT - 6 months ago

Cystic Fibrosis Foundation Commits Up to an Additional $24 Million for Prime Medicine to Develop Gene Editing Therapy

Prime Medicine Announces Additional Funding of Up to $24 Million from the Cystic Fibrosis Foundation to Advance Prime Editing Treatments for Cystic Fibrosis

Jul 16, 2025, 7:00 AM EDT - 6 months ago

Prime Medicine Announces Additional Funding of Up to $24 Million from the Cystic Fibrosis Foundation to Advance Prime Editing Treatments for Cystic Fibrosis

Prime Medicine: Pressing Forward With Lead Liver Targeting Indications

Jul 7, 2025, 4:45 PM EDT - 7 months ago

Prime Medicine: Pressing Forward With Lead Liver Targeting Indications

Prime Medicine Announces Strategic Restructuring to Focus on Opportunities in Large Genetic Liver Diseases, Cystic Fibrosis, and Partnered Programs Alongside CEO Leadership Transition

May 19, 2025, 8:31 AM EDT - 9 months ago

Prime Medicine Announces Strategic Restructuring to Focus on Opportunities in Large Genetic Liver Diseases, Cystic Fibrosis, and Partnered Programs Alongside CEO Leadership Transition

Prime Medicine Announces Breakthrough Clinical Data Showing Rapid Restoration of DHR Positivity After Single Infusion of PM359, an Investigational Prime Editor for Chronic Granulomatous Disease

May 19, 2025, 8:30 AM EDT - 9 months ago

Prime Medicine Announces Breakthrough Clinical Data Showing Rapid Restoration of DHR Positivity After Single Infusion of PM359, an Investigational Prime Editor for Chronic Granulomatous Disease

Prime Medicine Reports First Quarter 2025 Financial Results and Provides Business Updates

May 8, 2025, 8:00 AM EDT - 9 months ago

Prime Medicine Reports First Quarter 2025 Financial Results and Provides Business Updates

Prime Medicine Unveils Program for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)

Mar 18, 2025, 7:00 AM EDT - 11 months ago

Prime Medicine Unveils Program for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)

Prime Medicine Reports Full Year 2024 Financial Results and Provides Business Updates

Feb 28, 2025, 8:00 AM EST - 11 months ago

Prime Medicine Reports Full Year 2024 Financial Results and Provides Business Updates

Prime Medicine to Present at TD Cowen 45th Annual Health Care Conference

Feb 24, 2025, 8:00 AM EST - 1 year ago

Prime Medicine to Present at TD Cowen 45th Annual Health Care Conference

Kuehn Law Encourages Investors of Prime Medicine, Inc. to Contact Law Firm

Jan 30, 2025, 12:26 PM EST - 1 year ago

Kuehn Law Encourages Investors of Prime Medicine, Inc. to Contact Law Firm

Prime Medicine's Bristol Myers Partnership Boosts Outlook For Gene Editing Therapies

Nov 26, 2024, 5:10 AM EST - 1 year ago

Prime Medicine's Bristol Myers Partnership Boosts Outlook For Gene Editing Therapies

BMY

Wilson Disease Pipeline Market Research Report 2024: Comprehensive Insights on 5+ Drugs Featuring Vivet Therapeutics, Depymed, Prime Medicine, and Deep Genomics

Nov 21, 2024, 4:18 AM EST - 1 year ago

Wilson Disease Pipeline Market Research Report 2024: Comprehensive Insights on 5+ Drugs Featuring Vivet Therapeutics, Depymed, Prime Medicine, and Deep Genomics

Prime Medicine Presents In Vivo Proof-of-Concept Data Highlighting Interim Preclinical Advances in its Wilson's Disease Program and the Broad Potential of its Universal Liver-Targeted LNP at ESGCT 31st Annual Congress

Oct 24, 2024, 8:00 AM EDT - 1 year ago

Prime Medicine Presents In Vivo Proof-of-Concept Data Highlighting Interim Preclinical Advances in its Wilson's Disease Program and the Broad Potential of its Universal Liver-Targeted LNP at ESGCT 31st Annual Congress

Prime Medicine to Highlight New Preclinical Data, Including In Vivo Data in Wilson's Disease, at Upcoming Scientific Meetings

Oct 15, 2024, 8:00 AM EDT - 1 year ago

Prime Medicine to Highlight New Preclinical Data, Including In Vivo Data in Wilson's Disease, at Upcoming Scientific Meetings

Crude Oil Moves Higher; Prime Medicine Shares Spike Higher

Sep 30, 2024, 12:17 PM EDT - 1 year ago

Crude Oil Moves Higher; Prime Medicine Shares Spike Higher

Prime Medicine Inks Cell Therapy Pact With Bristol Myers Squibb Worth Over $3.5B, Streamlines Pipeline

Sep 30, 2024, 8:38 AM EDT - 1 year ago

Prime Medicine Inks Cell Therapy Pact With Bristol Myers Squibb Worth Over $3.5B, Streamlines Pipeline

BMY

Prime Medicine Unveils Strategically Focused Pipeline

Sep 30, 2024, 7:01 AM EDT - 1 year ago

Prime Medicine Unveils Strategically Focused Pipeline

Prime Medicine to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ

May 13, 2024, 8:00 AM EDT - 1 year ago

Prime Medicine to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ

Alphabet Bought Up Two Slumping Stocks

May 12, 2024, 3:00 AM EDT - 1 year ago

Alphabet Bought Up Two Slumping Stocks

GOOG GOOGL GTLB

Prime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updates

May 10, 2024, 8:00 AM EDT - 1 year ago

Prime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updates

Prime Medicine Presents Preclinical Data Demonstrating Ability of PM359 to Efficiently, Reproducibly and Durably Correct Causative Mutation of Chronic Granulomatous Disease (CGD)

May 8, 2024, 8:00 AM EDT - 1 year ago

Prime Medicine Presents Preclinical Data Demonstrating Ability of PM359 to Efficiently, Reproducibly and Durably Correct Causative Mutation of Chronic Granulomatous Disease (CGD)

Prime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)

Apr 29, 2024, 7:00 AM EDT - 1 year ago

Prime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)

Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology at Upcoming Scientific Meetings

Apr 23, 2024, 8:00 AM EDT - 1 year ago

Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology at Upcoming Scientific Meetings

Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updates

Mar 1, 2024, 8:00 AM EST - 2 years ago

Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updates

Prime Medicine Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

Feb 20, 2024, 4:01 PM EST - 2 years ago

Prime Medicine Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

Prime Medicine Announces Pricing of Upsized Public Offering

Feb 14, 2024, 11:50 PM EST - 2 years ago

Prime Medicine Announces Pricing of Upsized Public Offering

Prime Medicine's Investment Potential: A Deep Dive Into Innovation And Gene Editing

Jan 28, 2024, 8:11 AM EST - 2 years ago

Prime Medicine's Investment Potential: A Deep Dive Into Innovation And Gene Editing

Prime Medicine Receives Up to $15 Million from Cystic Fibrosis Foundation to Advance Hotspot and PASSIGE™ Prime Editors for Cystic Fibrosis

Jan 25, 2024, 8:00 AM EST - 2 years ago

Prime Medicine Receives Up to $15 Million from Cystic Fibrosis Foundation to Advance Hotspot and PASSIGE™ Prime Editors for Cystic Fibrosis

Cystic Fibrosis Foundation Funds Up to $15 Million to Prime Medicine to Pursue Gene Editing in CF

Jan 25, 2024, 8:00 AM EST - 2 years ago

Cystic Fibrosis Foundation Funds Up to $15 Million to Prime Medicine to Pursue Gene Editing in CF

Prime Medicine Appoints Allan Reine, M.D., as Chief Financial Officer

Jan 5, 2024, 8:00 AM EST - 2 years ago

Prime Medicine Appoints Allan Reine, M.D., as Chief Financial Officer

Prime Medicine to Present at 42nd Annual J.P. Morgan Healthcare Conference

Jan 2, 2024, 8:00 AM EST - 2 years ago

Prime Medicine to Present at 42nd Annual J.P. Morgan Healthcare Conference

AI In Biotech: A Revolutionary Leap Forward Or Just Another Buzzword?

Dec 1, 2023, 2:45 PM EST - 2 years ago

AI In Biotech: A Revolutionary Leap Forward Or Just Another Buzzword?

CRSP

Elamenape2
Elamenape2 Jan. 27 at 10:10 PM
$PRME
0 · Reply
arg195
arg195 Jan. 27 at 8:33 PM
$PRME wow look at that short squeeze predicted by our great 15 min chart reader @PorkchopSquats 😂😂
0 · Reply
IgotOptionsHere
IgotOptionsHere Jan. 27 at 8:23 PM
$PRME investors sitting on a pile of trash!
1 · Reply
PorkchopSquats
PorkchopSquats Jan. 27 at 6:21 PM
$PRME Just had to open my big dumb mouth.
0 · Reply
Mcnulty_jimmy
Mcnulty_jimmy Jan. 27 at 6:15 PM
$PRME its
0 · Reply
IgotOptionsHere
IgotOptionsHere Jan. 27 at 6:08 PM
$PRME what a steaming pile of shit!
0 · Reply
THE_Monkey_Banana_Genius
THE_Monkey_Banana_Genius Jan. 27 at 4:48 PM
$PRME setup on chart looks ripe. Long
1 · Reply
Montu11
Montu11 Jan. 27 at 4:28 PM
$PRME looking good this morning, but I’m conditioned now to know that this stock can’t seem to hold any gains for more than a couple days. Hoping to be proven wrong
1 · Reply
Benpsf
Benpsf Jan. 27 at 4:11 PM
$PRME Prime Medicine - Triple Bottom📈 Prime looks to have bottomed and is moving higher in the ascending channel
0 · Reply
KirRoyalTrader
KirRoyalTrader Jan. 27 at 3:08 PM
$PRME A prime setup for Prime Medicine, trading above all major moving averages. Notably, GOOGL holds this stock in its portfolio.
0 · Reply
arg195
arg195 Jan. 27 at 3:06 PM
$PRME @PorkchopSquats wow this might actually cause a short squeeze 😂
1 · Reply
WillyBoyQc
WillyBoyQc Jan. 27 at 2:59 PM
$PRME The battle to break the 4.30's decisively continues.
0 · Reply
603stockgoat
603stockgoat Jan. 27 at 2:54 PM
$PRME it’s prime time baby
0 · Reply
bjh33
bjh33 Jan. 27 at 2:52 PM
$NTLA Another hold will be lifted, then approved, holding not worried about this one. Also good for $PRME
0 · Reply
Mcnulty_jimmy
Mcnulty_jimmy Jan. 27 at 2:52 PM
$PRME Daily Deion
0 · Reply
PorkchopSquats
PorkchopSquats Jan. 27 at 2:36 PM
$PRME Jesus, and volume isn’t even heavy yet. This might actually cause a squeeze.
0 · Reply
burbs88
burbs88 Jan. 27 at 1:31 PM
$NTLA $CRSP $PRME Dark black cloud being lifted from entire sector today!
0 · Reply
FredGS
FredGS Jan. 27 at 1:06 PM
$PRME FDA lifted $NTLA hold. Should be good for the sector.
1 · Reply
SirSloth
SirSloth Jan. 27 at 1:34 AM
$PRME I'd be happy with a weekly close over 4.69
0 · Reply
Chet_Steadman
Chet_Steadman Jan. 26 at 10:36 PM
$PRME if this post gets 6 likes I’ll buy 15 shares rn
2 · Reply
PorkchopSquats
PorkchopSquats Jan. 26 at 5:14 PM
$ABCL $PRME On again reunited..
0 · Reply
TooPoorForPennyStocks
TooPoorForPennyStocks Jan. 26 at 5:09 PM
$PRME
1 · Reply